These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2307987)

  • 1. Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia.
    Schwarzinger I; Valent P; Köller U; Marosi C; Schneider B; Haas O; Knapp W; Lechner K; Bettelheim P
    J Clin Oncol; 1990 Mar; 8(3):423-30. PubMed ID: 2307987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML.
    Marosi C; Köller U; Koller-Weber E; Schwarzinger I; Schneider B; Jäger U; Vahls P; Nowotny H; Pirc-Danoewinata H; Steger G
    Cancer Genet Cytogenet; 1992 Jul; 61(1):14-25. PubMed ID: 1638477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia.
    Griffin JD; Davis R; Nelson DA; Davey FR; Mayer RJ; Schiffer C; McIntyre OR; Bloomfield CD
    Blood; 1986 Dec; 68(6):1232-41. PubMed ID: 2946331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies in myeloid diseases: prognostic use in acute myeloid leukaemia.
    Kristensen JS; Hokland P
    Leuk Res; 1991; 15(8):693-700. PubMed ID: 1895750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
    Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a novel surface antigen MKW in childhood acute leukemia has prognostic significance.
    Koehler M; Schell MJ; Behm FG; Raimondi SC; Woodruff LS; Mirro J
    Leukemia; 1991 Jan; 5(1):41-8. PubMed ID: 1999957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia.
    Dubosc-Marchenay N; Lacombe F; Dumain P; Marit G; Montastruc M; Belloc F; Reiffers J
    Hematol Oncol; 1992; 10(5):235-49. PubMed ID: 1493908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of standard CD assessment in acute leukemia.
    Tupitsyn NN; Babusíková O; Baryshnikov AYu ; Ujházy P; Kadagidze ZG; Mahonova LA; Peterson IS; Protasova AK; Drozdova TS; Artemjev AK
    Neoplasma; 1990; 37(4):431-8. PubMed ID: 2146517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
    Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
    Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
    Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis?
    Mason KD; Juneja SK; Szer J
    Blood Rev; 2006 Mar; 20(2):71-82. PubMed ID: 16185796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
    Paietta E; Andersen J; Gallagher R; Bennett J; Yunis J; Cassileth P; Rowe J; Wiernik PH
    Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
    Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
    Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD-15 antigen detected by the VIM-D5 monoclonal antibody for prediction of ability to achieve complete remission in acute nonlymphocytic leukemia.
    Hołowiecki J; Lutz D; Krzemień S; Stella-Hołowiecka B; Graf F; Kelenyi G; Schranz V; Callea V; Brugiatelli M; Neri A
    Acta Haematol; 1986; 76(1):16-9. PubMed ID: 3098022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis.
    Drexler HG; Menon M; Gaedicke G; Minowada J
    Cancer Immunol Immunother; 1986; 21(3):188-92. PubMed ID: 3457629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance.
    Lauria F; Raspadori D; Ventura MA; Rondelli D; Testoni N; Tosi P; Michieli M; Damiani D; Motta MR; Tura S
    Stem Cells; 1995 Jul; 13(4):428-34. PubMed ID: 7549902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected absence of a myeloid surface antigen (3-fucosyl-N-acetyllactosamine) in promyelocytic leukemia.
    Bettelheim P; Panzer S; Majdic O; Stockinger H; Roithner A; Köller U; Meryn S; Lechner K; Knapp W
    Leuk Res; 1985; 9(11):1323-7. PubMed ID: 3866114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.